£106.66

It has never been this cheap. We have no record of a lower price.

£107 today · cheaper than every other day in the last 3 months

Humana STAT Inhibitors in Cancer - Drug Discovery Development

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 50 days · 50 data points (no recent data)

Historical
Generating forecast…
£108.01 £106.52 £106.85 £107.17 £107.50 £107.82 £108.15 25 July 2026 06 August 2026 18 August 2026 30 August 2026 12 September 2026
View at Amazon ↗

Price data last checked 41 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 50 days • 2 price levels

Days at Price
Current Price
3 days · current 47 days 0 12 24 35 47 £107 £108 Days at Price

Price Analysis

Most common price: £108 (47 days, 94.0%)

Price range: £107 - £108

Price levels: 2 different prices over 50 days

Description

STAT Inhibitors in Cancer is a comprehensive medical reference that explores the latest advances in targeted cancer therapy through STAT inhibition. Written by leading scientists and clinicians, this volume examines the biology of STAT transcription factors and their critical role in cancer development, then systematically presents therapeutic approaches to inhibiting STATs across diverse cancer types. The book covers the full spectrum of inhibition strategies, from basic biological mechanisms to clinical applications, and features emerging clinical trial data that informs modern oncology practice. Essential for researchers, clinicians and healthcare professionals seeking evidence-based understanding of STAT-targeted therapies in modern cancer treatment.

Key Features

STAT Inhibitors in Cancer delivers state-of-the-art information on STAT family transcription factors and their involvement in cancer aetiology.

The volume presents comprehensive coverage of therapeutic approaches to inhibiting STATs across various cancer types and treatment contexts.

Contributions from leading scientists and clinicians provide expert perspectives on current STAT inhibition strategies and clinical applications.

Emerging clinical trial data is presented throughout to support understanding of STAT inhibitor efficacy in modern oncology practice.

The book combines biological foundations with practical clinical context for healthcare professionals and cancer researchers.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Signal Transducers and Activators of Transcription (STATs): Activation and Biology
95% match

Signal Transducers and Activators of Transcription (STATs): Activation and Biology

Springer

£166.01 25 Sep 2026
Wiley Statistical Thinking for Non-Statisticians in Drug Regulation
95% match

Wiley Statistical Thinking for Non-Statisticians in Drug Regulation

Wiley

£61.75 24 Aug 2026
Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)
94% match

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Humana

£169.76 26 Aug 2026
Statistical Methods in Biomarker and Early Clinical Development
94% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£100.08 24 Sep 2026
Chemistry and Pharmacology of Anticancer Drugs - CRC Press
94% match

Chemistry and Pharmacology of Anticancer Drugs - CRC Press

CRC Press

£126.97 02 Oct 2026
Chemistry and Pharmacology of Anticancer Drugs
94% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£205.87 02 Oct 2026
Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)
94% match

Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)

Humana

£81.74 12 Sep 2026
Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)
94% match

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

SAS Institute

£70.10 02 Oct 2026
Advances in Cancer Research: Vol. 88: Volume 88
94% match

Advances in Cancer Research: Vol. 88: Volume 88

Elsevier

£60.22 25 Sep 2026
Topics in Biostatistics: 404 (Methods in Molecular Biology, 404)
94% match

Topics in Biostatistics: 404 (Methods in Molecular Biology, 404)

Humana

£163.97 22 Aug 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
94% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£152.33 04 Sep 2026
Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)
94% match

Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£93.79 30 Sep 2026
Adverse Events and Oncotargeted Kinase Inhibitors
94% match

Adverse Events and Oncotargeted Kinase Inhibitors

Elsevier

£135.79 11 Sep 2026
Recent Advances in Biostatistics: False Discovery Rates, Survival Analysis, and Related Topics (Series in Biostatistics): 4
94% match

Recent Advances in Biostatistics: False Discovery Rates, Survival Analysis, and Related Topics (Series in Biostatistics): 4

World Scientific Publishing Company

£66.90 21 Sep 2026
Clinical Trial Biostatistics and Biopharmaceutical Applications
94% match

Clinical Trial Biostatistics and Biopharmaceutical Applications

CRC Press

£100.00 12 Sep 2026
Presenting Medical Statistics from Proposal to Publication
94% match

Presenting Medical Statistics from Proposal to Publication

Oxford University Press

£49.22 03 Sep 2026
Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)
94% match

Medical Statistics for Cancer Studies (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.44 11 Sep 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
94% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.21 12 Sep 2026
The Long and Short Non-coding RNAs in Cancer Biology: 927 (Advances in Experimental Medicine and Biology, 927)
94% match

The Long and Short Non-coding RNAs in Cancer Biology: 927 (Advances in Experimental Medicine and Biology, 927)

Springer

£83.79 24 Sep 2026
StataQuest 4 Windows 95 Version
94% match

StataQuest 4 Windows 95 Version

Cengage Learning

£70.79 03 Oct 2026
Recent Advances in Clinical Trial Design and Analysis: 75 (Cancer Treatment and Research, 75)
94% match

Recent Advances in Clinical Trial Design and Analysis: 75 (Cancer Treatment and Research, 75)

Springer

£144.16 30 Sep 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
94% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£120.00 17 Sep 2026
Biomedical Informatics for Cancer Research
94% match

Biomedical Informatics for Cancer Research

Springer

£107.85 03 Oct 2026
Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)
94% match

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Springer

£60.42 02 Oct 2026